117 related articles for article (PubMed ID: 15925829)
41. B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma.
Candolfi M; Curtin JF; Yagiz K; Assi H; Wibowo MK; Alzadeh GE; Foulad D; Muhammad AK; Salehi S; Keech N; Puntel M; Liu C; Sanderson NR; Kroeger KM; Dunn R; Martins G; Lowenstein PR; Castro MG
Neoplasia; 2011 Oct; 13(10):947-60. PubMed ID: 22028620
[TBL] [Abstract][Full Text] [Related]
42. Role of RANTES and its receptor in gastric cancer metastasis.
Cao Z; Xu X; Luo X; Li L; Huang B; Li X; Tao D; Hu J; Gong J
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):342-347. PubMed ID: 21671175
[TBL] [Abstract][Full Text] [Related]
43. CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy.
Xu T; Duan Q; Wang G; Hu B
Cell Biochem Biophys; 2011 Nov; 61(2):389-92. PubMed ID: 21607687
[TBL] [Abstract][Full Text] [Related]
44. Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.
Maruyama T; Mimura K; Izawa S; Shiba S; Watanabe M; Kawaguchi Y; Fujii H; Kono K
Nutrition; 2011 Feb; 27(2):146-52. PubMed ID: 21215924
[TBL] [Abstract][Full Text] [Related]
45. Regulatory T cells and breast cancer: implications for immunopathogenesis.
Watanabe MA; Oda JM; Amarante MK; Cesar Voltarelli J
Cancer Metastasis Rev; 2010 Dec; 29(4):569-79. PubMed ID: 20830504
[TBL] [Abstract][Full Text] [Related]
46. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
[TBL] [Abstract][Full Text] [Related]
47. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
[TBL] [Abstract][Full Text] [Related]
48. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
[TBL] [Abstract][Full Text] [Related]
49. Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients.
Kumar R; Kamdar D; Madden L; Hills C; Crooks D; O'Brien D; Greenman J
Oncol Rep; 2006 Jun; 15(6):1513-6. PubMed ID: 16685388
[TBL] [Abstract][Full Text] [Related]
50. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas.
Leung SY; Wong MP; Chung LP; Chan AS; Yuen ST
Acta Neuropathol; 1997 May; 93(5):518-27. PubMed ID: 9144591
[TBL] [Abstract][Full Text] [Related]
51. Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells.
Somasundaram A; Cillo AR; Lampenfeld C; Workman CJ; Kunning S; Oliveri L; Velez M; Joyce S; Calderon M; Dadey R; Rajasundaram D; Normolle DP; Watkins SC; Herman JG; Kirkwood JM; Lipson EJ; Ferris RL; Bruno TC; Vignali DAA
Cancer Immunol Res; 2022 Jul; 10(7):885-899. PubMed ID: 35587532
[TBL] [Abstract][Full Text] [Related]
52. Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells.
Martín-Manzo MV; Lara C; Vargas-de-Leon C; Carrero J; Queipo G; Fonseca-Sanchez M; Mejia-Dominguez NR; Kershenobich D; Mummidi S; Zentella-Dehesa A; Hernandez J
Pathol Oncol Res; 2019 Jul; 25(3):1233-1243. PubMed ID: 30759303
[TBL] [Abstract][Full Text] [Related]
53. Reply to Jiménez-Alonso et al., Schooling and Zhao, and Mortazavi: Further discussion on the immunological model of carcinogenesis.
Palmer S; Albergante L; Blackburn CC; Newman TJ
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4319-E4321. PubMed ID: 29669926
[No Abstract] [Full Text] [Related]
54. Thymic involution and rising disease incidence with age.
Palmer S; Albergante L; Blackburn CC; Newman TJ
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1883-1888. PubMed ID: 29432166
[TBL] [Abstract][Full Text] [Related]
55. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
Liu X; He L; Han J; Wang L; Li M; Jiang Y; Wang X; Yang Z
PLoS One; 2017; 12(2):e0170605. PubMed ID: 28231294
[TBL] [Abstract][Full Text] [Related]
56. The clinical significance of memory T cells and its subsets in gastric cancer.
Zhang R; Li F; Li H; Yu J; Ren X
Clin Transl Oncol; 2014 Mar; 16(3):257-65. PubMed ID: 23793812
[TBL] [Abstract][Full Text] [Related]
57. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
[TBL] [Abstract][Full Text] [Related]
58. Immune responses to malignancies.
Whiteside TL
J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S272-83. PubMed ID: 20061007
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
Albers AE; Schaefer C; Visus C; Gooding W; DeLeo AB; Whiteside TL
Head Neck; 2009 Jun; 31(6):773-81. PubMed ID: 19296526
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer.
Schaefer C; Kim GG; Albers A; Hoermann K; Myers EN; Whiteside TL
Br J Cancer; 2005 Mar; 92(5):913-20. PubMed ID: 15714205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
